LGALS13 anticorps (AA 30-139)
Aperçu rapide pour LGALS13 anticorps (AA 30-139) (ABIN7268198)
Antigène
Voir toutes LGALS13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 30-139
-
Fonction
- LGALS13 Rabbit pAb
-
Séquence
- FINDPQLQVD FYTDMDEDSD IAFRFRVHFG NHVVMNRREF GIWMLEETTD YVPFEDGKQF ELCIYVHYNE YEIKVNGIRI YGFVHRIPPS FVKMVQVSRD ISLTSVCVCN
-
Réactivité croisée
- Humain, Souris, Rat
-
Attributs du produit
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 30-139 of human LGALS13 (NP_037400.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))
-
Autre désignation
- LGALS13
-
Sujet
- Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene has lysophospholipase activity. It is composed of two identical subunits which are held together by disulfide bonds. This protein has structural similarity to several members of the beta-galactoside-binding S-type lectin family. [provided by RefSeq, Jul 2008],GAL13,PLAC8,PP13,LGALS13,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Blood,Serum Proteins,LGALS13
-
Poids moléculaire
- 16kDa
-
ID gène
- 29124
-
UniProt
- Q9UHV8
Antigène
-